Tomas Moks has a PhD in Biochemistry / Biotechnology form KTH. His research and industrial focus has been on the development and manufacturing of recombinant Biopharmaceuticals drugs. Over 30 years in leading positions in pharmaceutical companies, mainly in the Pharmacia sphere, within R&D, Global Supply and Business Development. Since 2010 he is acting as a consultant, helping small and midsized biotech companies with process development and cost effective outsourcing of their candidate drugs for manufacturing at external partners.
Dr Moks is group leader and principal investigator for the Cell factories for bioproduction program and responsible for coordination between the internal project and being main contact towards our industrial partner, Astra Zeneca Medimmune in Cambridge, UK.